加勒比西班牙裔人群阿尔茨海默病多基因风险评分
本研究在加勒比西班牙裔人群中构建并验证了祖先特异性晚发型阿尔茨海默病多基因风险评分(CH-PRS),发现其预测效能优于欧洲和非洲裔来源的PRS,且能预测纵向转化为LOAD。
要点
- CH-PRS联合年龄、性别和APOE-ε4的模型AUC达74%,在APOE-ε4非携带者中超过75%。
- CH-PRS单独在尸检队列中AUC为72%,全模型提升至83%。
- CH-PRS显著预测纵向转化为LOAD(HR=1.93,95%CI=1.70-2.20)。
核心结论
- 在加勒比西班牙裔人群中构建的祖先特异性PRS对晚发型阿尔茨海默病具有良好预测效能,优于欧洲和非洲裔来源的PRS。
- 遗传研究中的多样性 enrichment 对跨人群有效风险评估至关重要。
研究设计与样本
- 使用加勒比西班牙裔发现样本(n=4,312)和独立验证样本(n=1,850)构建CH-PRS。
- 在纵向子样本(n=1,239)中测试转化预测,并在独立复制队列(n=200)和脑尸检队列(n=33)中验证。
- 另用欧洲和非洲裔美国发现队列构建EUR-PRS和AA-PRS进行比较。
主要发现
- 全模型(CH-PRS+性别+年龄+APOE-ε4)AUC=74%(OR_CH-PRS=1.51,95%CI=1.36-1.68),APOE-ε4非携带者中>75%。
- CH-PRS单独在尸检队列AUC=72%,全模型AUC=83%。
- 复制队列中CH-PRS与临床LOAD显著相关(OR=1.61,95%CI=1.19-2.17)。
- 纵向子样本中CH-PRS显著预测转化为LOAD(HR=1.93,95%CI=1.70-2.20)。
- EUR-PRS和AA-PRS预测准确性较低(AUC分别为58%和53%)。
关键数值与推荐
- 全模型AUC=74%(OR_CH-PRS=1.51,95%CI=1.36-1.68),APOE-ε4非携带者中>75%。
- CH-PRS单独尸检队列AUC=72%,全模型AUC=83%。
- 复制队列OR=1.61(95%CI=1.19-2.17)。
- 纵向转化HR=1.93(95%CI=1.70-2.20)。
- EUR-PRS和AA-PRS的AUC分别为58%和53%。
临床怎么用
- 在加勒比西班牙裔人群中可考虑使用祖先特异性PRS辅助LOAD风险分层。
- PRS联合APOE-ε4、年龄和性别可提升预测效能。
- 跨人群应用PRS需注意祖先特异性,非欧洲来源PRS预测准确性较低。
局限性
- 发现和验证样本均限于加勒比西班牙裔,外推至其他人群需谨慎。
- 尸检队列样本量较小(n=33),纵向子样本n=1,239。
- 未报告其他潜在混杂因素或模型校准信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Polygenic risk scores (PRSs) assess the individual genetic propensity to a condition by combining sparse information scattered across genetic loci, often displaying small effect sizes. Most PRSs are constructed in European-ancestry populations, limiting their use in other ethnicities. Here we constructed and validated a PRS for late-onset Alzheimer's Disease (LOAD) in Caribbean Hispanics (CH). METHODS: We used a CH discovery (n = 4,312) and independent validation sample (n = 1,850) to construct an ancestry-specific PRS ("CH-PRS") and evaluated its performance alone and with other predictors using the area under curve (AUC) and logistic regression (strength of association with LOAD and statistical significance). We tested if CH-PRS predicted conversion to LOAD in a subsample with longitudinal data (n = 1,239). We also tested the CH-PRS in an independent replication CH cohort (n = 200) and brain autopsy cohort (n = 33). Finally, we tested the effect of ancestry on PRS by using European and African American discovery cohorts to construct alternative PRSs ("EUR-PRS", "AA-PRS"). RESULTS: The full model (LOAD ~ CH-PRS + sex + age + APOE-ɛ4), achieved an AUC = 74% (ORCH-PRS = 1.51 95%CI = 1.36-1.68), raising to >75% in APOE-ɛ4 non-carriers. CH-PRS alone achieved an AUC = 72% in the autopsy cohort, raising to AUC = 83% in full model. Higher CH-PRS was significantly associated with clinical LOAD in the replication CH cohort (OR = 1.61, 95%CI = 1.19-2.17) and significantly predicted conversion to LOAD (HR = 1.93, CI = 1.70-2.20) in the longitudinal subsample. EUR-PRS and AA-PRS reached lower prediction accuracy (AUC = 58% and 53%, respectively). INTERPRETATION: Enriching diversity in genetic studies is critical to provide an effective PRS in profiling LOAD risk across populations. ANN NEUROL 2021;90:366-376.
引用
- Sariya S, Felsky D, Reyes-Dumeyer D, et al. Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics. Ann Neurol. 2021. PMID: 34038570. doi:10.1002/ana.26131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。